Paul J. Goodfellow
Affiliations: | Biology & Biomedical Sciences (Developmental Biology) | Washington University, Saint Louis, St. Louis, MO |
Area:
Genetics, Human Development, Molecular Biology, OncologyGoogle:
"Paul Goodfellow"Children
Sign in to add trainee| Ferrin C. Noonan | grad student | 2002 | Washington University |
| Omar Kabbarah | grad student | 2003 | Washington University |
| Katherine B. Chiappinelli | grad student | 2012 | Washington University |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Riedinger CJ, Esnakula A, Haight PJ, et al. (2023) Characterization of mismatch-repair (MMR)/microsatellite instability (MSI)-discordant endometrial cancers. Cancer |
| Hampel H, Pearlman R, de la Chapelle A, et al. (2021) Double somatic mismatch repair gene pathogenic variants as common as Lynch syndrome among endometrial cancer patients. Gynecologic Oncology. 160: 161-168 |
| Koivisto CS, Parrish M, Bonala SB, et al. (2020) Evaluating the efficacy of enzalutamide and the development of resistance in a preclinical mouse model of type-I endometrial carcinoma. Neoplasia (New York, N.Y.). 22: 484-496 |
| Konstantinopoulos PA, Norquist B, Lacchetti C, et al. (2020) Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1902960 |
| Koivisto CS, Melodie P, Santosh B, et al. (2020) Abstract 627: Evaluating the efficacy of enzalutamide and the development of resistance in a preclinical mouse model of type-I endometrial carcinoma Cancer Research. 80: 627-627 |
| Moyer CL, Ivanovich J, Gillespie JL, et al. (2019) Rare BRIP1 missense alleles confer risk for ovarian and breast cancer. Cancer Research |
| Aryal NK, Pant V, Wasylishen AR, et al. (2019) Dicer1 phospho-mimetic promotes tumor progression and dissemination. Cancer Research |
| Brooks RA, Tritchler DS, Darcy KM, et al. (2019) GOG 8020/210: Risk stratification of lymph node metastasis, disease progression and survival using single nucleotide polymorphisms in endometrial cancer: An NRG oncology/gynecologic oncology group study. Gynecologic Oncology |
| Rush CM, Goodfellow PJ. (2019) Diverse mutational signatures in endometrial cancer: implications for tumor etiology and evolution. Gynecologic Oncology. 152: 1-2 |
| Backes FJ, Haag J, Cosgrove CM, et al. (2018) Mismatch repair deficiency identifies patients with high-intermediate-risk (HIR) endometrioid endometrial cancer at the highest risk of recurrence: A prognostic biomarker. Cancer |